Examining the association between medication adherence trajectories and disease-specific clinical outcomes: An analysis focusing on the drug classes included in Part D quality bonus payments [0.03%]
探究用药依从性变化与疾病特异性临床结果之间的关联：以D部分质量奖金支付所涵盖的药物类别为重点的一项分析
Vasco M Pontinha,Dave L Dixon,Norman V Carroll et al.
Vasco M Pontinha et al.
Background: Quality initiatives such as the Medicare Part D Star Ratings program rely on medication adherence measurements. Prior research characterized the longitudinal patterns of adherence to medications for chronic co...
Impact of a pharmacy care management service on cardiometabolic medication adherence and resource use for Medicare Advantage beneficiaries [0.03%]
药房护理管理服务对医疗补助优势受益者的心血管代谢药物依从性和资源使用的影响
Shawn Hallinan,Loren Lidsky,Josh Benner et al.
Shawn Hallinan et al.
Background: Prescribing rates and adherence to evidence-based cardiometabolic medications remain suboptimal. Many strategies to improve prescribing and adherence have been developed, among which pharmacy care management (...
The AMCP Poster Abstract Program provides a forum for authors to share their research with the managed care pharmacy community. Authors submit their abstracts to AMCP, and each abstract is reviewed by a team of peer reviewers and editors. A...
Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis [0.03%]
美国全国理赔分析显示血红素合成障碍患者疾病负担及未被满足的需求：一项基于大量美国全国的理赔数据分析
Maral DerSarkissian,Chelsea Norregaard,Hela Romdhani et al.
Maral DerSarkissian et al.
Background: Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are rare genetic disorders caused by the accumulation of the toxic metabolite protoporphyrin IX, which results in painful phototoxicity upo...
Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetes [0.03%]
美国成人2型糖尿病患者使用胰高血糖素样肽-1受体激动剂的相关模式和费用
Jun Wu,Alexandra Perez,Patrick W Sullivan
Jun Wu
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) offer cardiorenal benefits in diabetes management. Since 2020, public awareness of GLP-1 RAs for diabetes, weight loss, and the prevention of cardiovascula...
Clinical and economic impact of recurrence in unresected non-small cell lung cancer treated with primary stereotactic body radiotherapy: A real-world study using SEER-Medicare data [0.03%]
基于SEER-Medicare数据的不可手术非小细胞肺癌立体定向体部放射治疗原发灶后的复发临床及经济影响：一项真实世界研究
Pragya Rai,Andrew Song,Su Zhang et al.
Pragya Rai et al.
Background: Stereotactic body radiotherapy (SBRT) is the recommended treatment for inoperable, early-stage non-small cell lung cancer (NSCLC). Although prior research has assessed overall survival (OS) and recurrence rate...
Trends in opioid prescribing by oncologists for Medicare beneficiaries from 2014 to 2022 [0.03%]
2014至2022年美国老年医学会疼痛管理专家阿片类药方的开写趋势
Shaimaa Elshafie,Lorenzo Villa Zapata
Shaimaa Elshafie
Background: Overprescribing of opioids has led to hundreds of thousands of overdose deaths and substantial health care costs. In response, the US Food and Drug Administration (FDA) implemented a revised Risk Evaluation an...
Examining racial and ethnic differences in health care expenditures among older adults with arthritis in the United States [0.03%]
美国老年人患关节炎的医疗开支的种族和民族差异分析
Samuel C Ofili,Paroma Arefin,Olajumoke A Olateju et al.
Samuel C Ofili et al.
Background: More than 65 million Americans suffer from arthritis, which is the primary cause of disability in older adults. Arthritis is also a leading disease, with more than $600 billion in medical expenses each year. T...
Impact of copay maximizers on total patient liability among patients using specialty medicines [0.03%]
共付额最大化对使用特药患者的总自付费用的影响
Daniel Sheinson,Achal Patel,William B Wong
Daniel Sheinson
Background: Insurers increasingly use copay maximizer programs to control costs. Although these programs shield patients from out-of-pocket (OOP) exposure for drugs, the impact on OOP costs for other health care services ...
A systematic review of the applications of the real option value of medical technologies in oncology [0.03%]
医学技术实值选项在肿瘤学中的应用系统回顾
Kwame Adjei,Vakaramoko Diaby,Meng Li et al.
Kwame Adjei et al.
Background: Real option value (ROV) offers an innovative paradigm to evaluate the dynamic value of medical technologies, particularly in cancer, by capturing the value of extending patient survival to access future innova...